Utah Medical Products (UTMD) Revenue (2010 - 2026)

Utah Medical Products has reported Revenue for 17 years, with the latest figure at $8.5 million in Q2 2026.

• On a quarterly basis, Revenue fell 14.31% year-over-year to $8.5 million in Q2 2026; TTM through Jun 2026 was $36.1 million, a 7.0% decrease from a year earlier, with the FY2025 full-year figure at $38.5 million, down 5.83% from the prior year.
• Revenue was $8.5 million for Q2 2026 at Utah Medical Products, down from $8.7 million in the prior quarter.
• The five-year high for Revenue was $13.6 million in Q4 2022, with the low at $8.5 million in Q2 2026.
• Average Revenue over 5 years is $11.1 million, with a median of $10.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Revenue climbed 12.4% in 2022, then dropped 25.75% in 2024.
• Over 5 years, Revenue stood at $13.6 million in 2022, then decreased by 9.15% to $12.3 million in 2023, then slipped by 25.75% to $9.2 million in 2024, then decreased by 1.23% to $9.0 million in 2025, then retreated by 5.69% to $8.5 million in 2026.
• The last three Revenue figures came in at $8.5 million (Q2 2026), $8.7 million (Q1 2026), and $9.0 million (Q4 2025), per Business Quant data.